miR-30a-5p
rnamiR-30a-5p links dysbiotic microbiota-derived dysregulation to intestinal barrier permeability and MI pathogenesis via ABCC1 suppression.
Pathway placement
Cascade stepOff-pathway / systemic markers
Confidencemedium
RationaleGut microbiota-mediated regulator of ABCC1; systemic axis integrating microbiota dysbiosis with MI risk.
Also acts inVascular inflammation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood or cell-free plasma
Collection tube
PAXgene/Tempus RNA tube · K2/K3-EDTA (lavender-top)
Method / principle
RT-qPCR (TaqMan) or small-RNA sequencing
Reagent / substrate
Target-specific primers/probe; reverse transcriptase (miRNA: stem-loop RT primer)
Platform
qPCR instrument / NGS
Turnaround · availability
Research / send-out · Research (few LDTs)
Literature evidence(1)
- The gut microbiotas with metabolites regulate the protective role of miR-30a-5p in myocardial infarction.Journal of advanced research · 2024 · PMID 39442873 · doi